231 related articles for article (PubMed ID: 16037763)
21. Effects of different progestogens on human breast tumor cell growth.
Chen FP; Chien MH; Chen HY; Ng YT
Climacteric; 2011 Jun; 14(3):345-51. PubMed ID: 21375453
[TBL] [Abstract][Full Text] [Related]
22. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
23. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract.
Africander D; Louw R; Verhoog N; Noeth D; Hapgood JP
Contraception; 2011 Oct; 84(4):423-35. PubMed ID: 21920200
[TBL] [Abstract][Full Text] [Related]
25. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
[TBL] [Abstract][Full Text] [Related]
26. Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo.
Ochnik AM; Moore NL; Jankovic-Karasoulos T; Bianco-Miotto T; Ryan NK; Thomas MR; Birrell SN; Butler LM; Tilley WD; Hickey TE
Menopause; 2014 Jan; 21(1):79-88. PubMed ID: 23715406
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of human breast epithelial cells in vitro to hormones and drugs.
Calaf GM
Int J Oncol; 2006 Feb; 28(2):285-95. PubMed ID: 16391781
[TBL] [Abstract][Full Text] [Related]
28. Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors?
Seeger H; Wallwiener D; Mueck AO
Eur J Gynaecol Oncol; 2006; 27(2):139-41. PubMed ID: 16620055
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
[TBL] [Abstract][Full Text] [Related]
30. Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells.
Jeng MH; Jordan VC
Mol Endocrinol; 1991 Aug; 5(8):1120-8. PubMed ID: 1834933
[TBL] [Abstract][Full Text] [Related]
31. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
33. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional profiles of progestogen effects in the postmenopausal breast.
Wood CE; Register TC; Cline JM
Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
[TBL] [Abstract][Full Text] [Related]
35. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
Lockwood CJ
Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
[TBL] [Abstract][Full Text] [Related]
36. Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis.
Pompei LM; Cunha EP; Steiner ML; Theodoro TR; Mader AM; Petri G; Pinhal MA; Fernandes CE
Climacteric; 2015; 18(4):518-22. PubMed ID: 25830529
[TBL] [Abstract][Full Text] [Related]
37. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
38. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.
Tomasicchio M; Avenant C; Du Toit A; Ray RM; Hapgood JP
PLoS One; 2013; 8(5):e62895. PubMed ID: 23658782
[TBL] [Abstract][Full Text] [Related]
39. Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Ruan X; Gu M; Cai G; Zhao Y; Wang L; Li X; Mueck AO
Maturitas; 2019 May; 123():1-8. PubMed ID: 31027671
[TBL] [Abstract][Full Text] [Related]
40. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
